Annual Total Debt
$262.80 K
-$218.50 K-45.40%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual total debt is $262.80 thousand, with the most recent change of -$218.50 thousand (-45.40%) on September 30, 2024.
- During the last 3 years, CTXR annual total debt has fallen by -$592.60 thousand (-69.28%).
- CTXR annual total debt is now -80.56% below its all-time high of $1.35 million, reached on September 30, 2020.
Performance
CTXR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$262.80 K
-$57.20 K-17.88%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly total debt is $262.80 thousand, with the most recent change of -$57.20 thousand (-17.88%) on September 30, 2024.
- Over the past year, CTXR quarterly total debt has dropped by -$57.20 thousand (-17.88%).
- CTXR quarterly total debt is now -95.15% below its all-time high of $5.42 million, reached on June 30, 2017.
Performance
CTXR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
CTXR Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.4% | -17.9% |
| 3 y3 years | -69.3% | -17.9% |
| 5 y5 years | +51.9% | -17.9% |
CTXR Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.3% | at low | -67.7% | at low |
| 5 y | 5-year | -80.6% | +51.9% | -81.1% | at low |
| alltime | all time | -80.6% | -100.0% | -95.2% | -100.0% |
Citius Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $262.80 K(-45.4%) | $262.80 K(-17.9%) |
| Jun 2024 | - | $320.00 K(-14.6%) |
| Mar 2024 | - | $374.80 K(-12.6%) |
| Dec 2023 | - | $428.60 K(-10.9%) |
| Sep 2023 | $481.30 K(-29.0%) | $481.30 K(-9.7%) |
| Jun 2023 | - | $532.90 K(-8.5%) |
| Mar 2023 | - | $582.30 K(-7.7%) |
| Dec 2022 | - | $630.80 K(-7.0%) |
| Sep 2022 | - | $678.20 K(-6.4%) |
| Sep 2022 | $678.20 K(-20.7%) | - |
| Jun 2022 | - | $724.80 K(-5.8%) |
| Mar 2022 | - | $769.20 K(-5.4%) |
| Dec 2021 | - | $812.70 K(-5.0%) |
| Sep 2021 | $855.40 K(-36.7%) | $855.40 K(-19.4%) |
| Jun 2021 | - | $1.06 M(-16.7%) |
| Mar 2021 | - | $1.27 M(-3.0%) |
| Dec 2020 | - | $1.31 M(-2.8%) |
| Sep 2020 | $1.35 M(+681.6%) | $1.35 M(-2.7%) |
| Jun 2020 | - | $1.39 M(+10.2%) |
| Mar 2020 | - | $1.26 M(-2.7%) |
| Dec 2019 | - | $1.30 M(+648.8%) |
| Sep 2019 | $173.00 K(0.0%) | $173.00 K(0.0%) |
| Jun 2019 | - | $173.00 K(0.0%) |
| Mar 2019 | - | $173.00 K(0.0%) |
| Dec 2018 | - | $173.00 K(0.0%) |
| Sep 2018 | $173.00 K | $173.00 K(0.0%) |
| Jun 2018 | - | $173.00 K(0.0%) |
| Mar 2018 | - | $173.00 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | - | $173.00 K(0.0%) |
| Sep 2017 | $173.00 K(-74.3%) | $173.00 K(-96.8%) |
| Jun 2017 | - | $5.42 M(+167.7%) |
| Mar 2017 | - | $2.02 M(+35.5%) |
| Dec 2016 | - | $1.49 M(+121.8%) |
| Sep 2016 | $673.00 K(>+9900.0%) | $673.00 K(+289.0%) |
| Jun 2016 | - | $173.00 K(-77.6%) |
| Mar 2016 | - | $773.00 K(>+9900.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sep 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(-100.0%) |
| Sep 2014 | $600.00 K(>+9900.0%) | $600.00 K(+1954.8%) |
| Jun 2014 | - | $29.20 K(+20.7%) |
| Mar 2014 | - | $24.20 K(+16.9%) |
| Dec 2013 | - | $20.70 K(+546.9%) |
| Sep 2013 | $3200.00(-91.7%) | $3200.00(-93.8%) |
| Jun 2013 | - | $51.80 K(+6.6%) |
| Mar 2013 | - | $48.60 K(+24.9%) |
| Dec 2012 | - | $38.90 K(+0.5%) |
| Sep 2012 | $38.70 K(>+9900.0%) | $38.70 K(+16.2%) |
| Jun 2012 | - | $33.30 K(+22.4%) |
| Mar 2012 | - | $27.20 K(+31.4%) |
| Dec 2011 | - | $20.70 K(>+9900.0%) |
| Sep 2011 | $0.00 | $0.00(-100.0%) |
| Jun 2011 | - | $13.40 K(>+9900.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00 |
FAQ
- What is Citius Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual total debt year-on-year change?
- What is Citius Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly total debt year-on-year change?
What is Citius Pharmaceuticals annual total debt?
The current annual total debt of CTXR is $262.80 K
What is the all time high annual total debt for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual total debt is $1.35 M
What is Citius Pharmaceuticals annual total debt year-on-year change?
Over the past year, CTXR annual total debt has changed by -$218.50 K (-45.40%)
What is Citius Pharmaceuticals quarterly total debt?
The current quarterly total debt of CTXR is $262.80 K
What is the all time high quarterly total debt for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly total debt is $5.42 M
What is Citius Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, CTXR quarterly total debt has changed by -$57.20 K (-17.88%)